Universidad Complutense de Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2008

  1. Nuclear exclusion of forkhead box O and Elk1 and activation of nuclear factor-κB are required for C2C12-RasV12C40 myoblast differentiation

    Endocrinology, Vol. 149, Núm. 2, pp. 793-801

2006

  1. Potentiation of tumor formation by topical administration of 15-deoxy-Δ12,14-prostaglandin J2 in a model of skin carcinogenesis

    Carcinogenesis, Vol. 27, Núm. 2, pp. 328-336

2005

  1. Sprouty-2 overexpression in C2C12 cells confers myogenic differentiation properties in the presence of FGF2

    Molecular Biology of the Cell, Vol. 16, Núm. 9, pp. 4454-4461

2004

  1. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras

    Journal of Biological Chemistry, Vol. 279, Núm. 32, pp. 33480-33491

2003

  1. H-Ras-specific activation of NF-κB protects NIH 3T3 cells against stimulus-dependent apoptosis

    Oncogene, Vol. 22, Núm. 4, pp. 477-483

  2. The cyclopentenone 15-deoxy-Δ 12, 14-prostaglandin J2 binds to and activates H-Ras

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, Núm. 8, pp. 4772-4777